NATCOPHARM has declared results for the period ended Mar 2021.
Quarterly Results
[s2If !current_user_can(access_s2member_level1)] Register and Login below to read result analysis [lwa][/s2If] [s2If current_user_can(access_s2member_level1)]
- Sales for period ended Mar 2021 is Rs 331.0 cr compared to Rs 455.0 cr for period ended Mar 2020, a fall of 27.3%
- Operating Profits reported at Rs 76.0 cr for period ended Mar 2021 vis-vis 128.0 for period ended Mar 2020 .
- Operating Margins contracted -517.1 bps for period ended Mar 2021 vis-vis Mar 2020 .
- The EPS for Mar 2021 was Rs 2.91 compared to Rs 3.44 for previous quarter ended Dec 2020 and Rs 5.17 for Mar 2020
- The stock is trading at Rs 1131 and a market cap of Rs 20618 cr
[/s2If]Further analysis and Full Company Research with investing scores is available here: NATCOPHARM